Skip to main navigation Skip to search Skip to main content

Antibodies against chlamydia trachomatis and ovarian cancer risk in two independent populations

  • Britton Trabert*
  • , Tim Waterboer
  • , Annika Idahl
  • , Nicole Brenner
  • , Louise A. Brinton
  • , Julia Butt
  • , Sally B. Coburn
  • , Patricia Hartge
  • , Katrin Hufnagel
  • , Federica Inturrisi
  • , Jolanta Lissowska
  • , Alexander Mentzer
  • , Beata Peplonska
  • , Mark E. Sherman
  • , Gillian S. Wills
  • , Sarah C. Woodhall
  • , Michael Pawlita
  • , Nicolas Wentzensen
  • *Corresponding author for this work
  • National Institutes of Health
  • German Cancer Research Center
  • Umeå University
  • German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Maria Sklodowska-Curie Institute of Oncology
  • University of Oxford
  • Nofer Institute of Occupational Medicine
  • Mayo Clinic Jacksonville, FL
  • Imperial College London
  • UK Health Security Agency
  • University College London
  • Gloucestershire Hospitals NHS Foundation Trust

Research output: Contribution to journalArticleAcademicpeer-review

9 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Antibodies against chlamydia trachomatis and ovarian cancer risk in two independent populations'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Medicine and Dentistry

Keyphrases